Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00271934 · ClinicalTrials.gov registry record · Phase 2
Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II Study
A Phase 2 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 2
- Development phase
- 52
- Enrollment target
NCT00271934 is a Phase 2 study that has completed, run by Northwestern University. The registered enrollment target is 52 participants.
The verdict
NCT00271934, a Phase 2 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 52 participants
- Enrollment target
Study Summary
In patients with systemic lupus erythematosus, immunosuppressive therapy to the point of complete immune ablation and hematopoietic stem cell recovery.
Interventions
- BIOLOGICAL Immune ablation and hematopoietic stem cell support.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2002-09 |
| Est. Completion | 2012-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00271934
The ClinicalTrials.gov registry entry for NCT00271934 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Immune ablation and hematopoietic stem cell support. is the first listed.
NCT00271934 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00271934 about?
NCT00271934 is a clinical study titled "Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II Study". In patients with systemic lupus erythematosus, immunosuppressive therapy to the point of complete immune ablation and hematopoietic stem cell recovery.
What is the current status of trial NCT00271934?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 52 participants. The study started on 2002-09. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00271934?
The interventions under investigation include: Immune ablation and hematopoietic stem cell support. (BIOLOGICAL).
Who is sponsoring clinical trial NCT00271934?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.